Reported 2 days ago
The article examines Eli Lilly and Company (LLY) amidst rising market volatility, especially due to geopolitical tensions and economic uncertainty affecting the US stock market in early 2025. It highlights LLY's low volatility stock standing in a turbulent environment, its strategic growth through acquisitions, and its recent successes in drug trials, suggesting it as a solid choice for conservative investors despite potential risks from trade policies.
Source: YAHOO